| Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration Journal of Clinical Oncology 26 (35), 5802, 2008 | 877 | 2008 |
| Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre … MJM van der Valk, DE Hilling, E Bastiaannet, EMK Kranenbarg, GL Beets, ... The Lancet 391 (10139), 2537-2545, 2018 | 875 | 2018 |
| Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second … K Nygaard, S Hagen, HS Hansen, R Hatlevoll, R Hultborn, A Jakobsen, ... World journal of surgery 16, 1104-1109, 1992 | 789 | 1992 |
| Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG) GJS Rustin, I Vergote, E Eisenhauer, E Pujade-Lauraine, M Quinn, ... International Journal of Gynecologic Cancer 21 (2), 2011 | 615 | 2011 |
| High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study AL Appelt, J Pløen, H Harling, FS Jensen, LH Jensen, JCR Jørgensen, ... The lancet oncology 16 (8), 919-927, 2015 | 548 | 2015 |
| Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer) GJS Rustin, M Quinn, T Thigpen, A Du Bois, E Pujade-Lauraine, ... Journal of the National Cancer Institute 96 (6), 487-488, 2004 | 355 | 2004 |
| Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy D Edler, B Glimelius, M Hallström, A Jakobsen, PG Johnston, ... Journal of Clinical Oncology 20 (7), 1721-1728, 2002 | 351 | 2002 |
| Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan KLG Spindler, N Pallisgaard, I Vogelius, A Jakobsen Clinical Cancer Research 18 (4), 1177-1185, 2012 | 326 | 2012 |
| Surveillance following orchidectomy for stage I seminoma of the testis H von der Maase, L Specht, GK Jacobsen, A Jakobsen, EL Madsen, ... European journal of cancer 29 (14), 1931-1934, 1993 | 325 | 1993 |
| Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene Polymorphism in Normal Tissue As Predictors of Fluorouracil Sensitivity A Jakobsen, JN Nielsen, N Gyldenkerne, J Lindeberg Journal of clinical oncology 23 (7), 1365-1369, 2005 | 280 | 2005 |
| Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer] I Vergote, GJS Rustin, EA Eisenhauer, GB Kristensen, E Pujade-Lauraine, ... Journal of the National Cancer Institute 92 (18), 1534-1535, 2000 | 280 | 2000 |
| Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy AL Appelt, J Pløen, IR Vogelius, SM Bentzen, A Jakobsen International Journal of Radiation Oncology* Biology* Physics 85 (1), 74-80, 2013 | 275 | 2013 |
| Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta‐analysis Chemoradiotherapy for Cervical Cancer Meta‐analysis Collaboration The Cochrane Database of Systematic Reviews 2010 (1), 2010 | 232 | 2010 |
| Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer JS Nielsen, E Jakobsen, B Hølund, K Bertelsen, A Jakobsen International Journal of Gynecologic Cancer 14 (6), 2004 | 219 | 2004 |
| A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial … K Bertelsen, A Jakobsen, I Strøyer, K Nielsen, E Sandberg, JE Andersen, ... Gynecologic oncology 49 (1), 30-36, 1993 | 186 | 1993 |
| Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study. A Jakobsen, K Bertelsen, JE Andersen, H Havsteen, P Jakobsen, ... Journal of clinical oncology 15 (1), 193-198, 1997 | 171 | 1997 |
| Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer KLG Spindler, N Pallisgaard, RF Andersen, I Brandslund, A Jakobsen PloS one 10 (4), e0108247, 2015 | 157 | 2015 |
| Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group B Glimelius, O Dahl, B Cedermark, A Jakobsen, SM Bentzen, ... Acta oncologica 44 (8), 904-912, 2005 | 156 | 2005 |
| Granulosa cell tumor of the ovary: a population-based study of 37 women with stage I disease FF Lauszus, AC Petersen, J Greisen, A Jakobsen Gynecologic oncology 81 (3), 456-460, 2001 | 153 | 2001 |
| Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch … LM Fernandez, GP São Julião, NL Figueiredo, GL Beets, ... The Lancet Oncology 22 (1), 43-50, 2021 | 147 | 2021 |
